Robert Adam Mitchell

Head of MR-linac Physics

Royal Marsden Hospital Sutton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Adam Mitchell is the Head of MR-linac Physics at Royal Marsden Hospital Sutton in the United Kingdom. His research primarily focuses on MRI-guided adaptive radiotherapy, with significant contributions to the fields of prostate and pancreatic cancer treatment. Recent publications include studies on the effects of daily MRI-guided adaptive radiotherapy for localized prostate cancer and the development of international consensus protocols for MR-guided SBRT. His work aims to enhance the precision and efficacy of radiotherapy practices.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (4)

Douglas Brand

University College London

UNITED KINGDOM

View details

robert huddart

Institute of Cancer Research

UNITED KINGDOM

View details

Emma Hall

Institute of Cancer Research

UNITED KINGDOM

View details

Alex Dunlop

Head of Adaptive Techniques

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Adam Mitchell

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Ultrahypofractionated radiotherapy for localised prostate cancer: The impact of daily MRI-guided adaptive radiotherapy on delivered dose

MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study

Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments

Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol.

Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy

Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy

Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy

Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI

Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study

Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?

Collaborators (4)

Douglas Brand

robert huddart

Emma Hall

Alex Dunlop

Make your next move.